<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02924324</url>
  </required_header>
  <id_info>
    <org_study_id>16-1417</org_study_id>
    <nct_id>NCT02924324</nct_id>
  </id_info>
  <brief_title>Local Injection of Pain Medication to Reduce Pain After Bone Marrow Procedures in Pediatric Neuroblastoma Patients</brief_title>
  <official_title>RePPAIR -Reducing Procedural Pain and Improving Recovery of Quality of Life in Pediatric Neuroblastoma Patients Undergoing Bone Marrow Procedures: A Prospective Randomized Cross-over Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Memorial Sloan Kettering Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Memorial Sloan Kettering Cancer Center</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to identify whether or not the addition of a numbing medicine&#xD;
      that is injected directly into the site of the bone marrow procedure can reduce pain and the&#xD;
      use of opioid pain medication after bone marrow procedures. The addition of this medicine,&#xD;
      called ropivacaine, is the experimental part of this study. This is the first time&#xD;
      ropivacaine will be directly injected into the bone marrow site at MSKCC Pediatrics.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Actual">November 2019</completion_date>
  <primary_completion_date type="Actual">November 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the proportion of patients requiring post-procedural opioid analgesia</measure>
    <time_frame>within 24 hours (+/- 4 hours) post procedure</time_frame>
    <description>Post-operative pain reported on the Wong-Baker FACES® Pain Rating Scale (converted to scale of 0-10) will be measured</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">56</enrollment>
  <condition>Neuroblastoma</condition>
  <arm_group>
    <arm_group_label>propofol alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1st Bone Marrow procedure (BM) Intervention A: propofol alone. Crossover for second BM procedure propofol &amp; ropivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>propofol and ropivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1st BM procedure: Intervention B: propofol &amp; ropivacaine. Crossover for second BM procedure propofol alone</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>propofol</intervention_name>
    <arm_group_label>propofol alone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ropivacaine</intervention_name>
    <arm_group_label>propofol and ropivacaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Wong-Baker FACES® Pain Rating Scale</intervention_name>
    <description>Nurses will record patient-reported pain scores.</description>
    <arm_group_label>propofol alone</arm_group_label>
    <arm_group_label>propofol and ropivacaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Post-procedural quality of life (QOL)</intervention_name>
    <arm_group_label>propofol alone</arm_group_label>
    <arm_group_label>propofol and ropivacaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of neuroblastoma as defined by the International Neuroblastoma Risk Group&#xD;
             Staging System (INRGSS)22&#xD;
&#xD;
          -  3 - 18 years of age&#xD;
&#xD;
          -  Patient has had prior bone marrow procedures&#xD;
&#xD;
          -  English speaking&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of allergy to investigational agent: ropivacaine or other amino amide&#xD;
             analgesics&#xD;
&#xD;
          -  History of allergy to standard agent: propofol&#xD;
&#xD;
          -  Chronic daily opioid requirement&#xD;
&#xD;
          -  Lansky/Karnofsky Score &lt; 60&#xD;
&#xD;
          -  Inability to comply with protocol requirements including refusal to forego&#xD;
             pre-procedural opioid use&#xD;
&#xD;
          -  Patient is receiving additional potentially painful interventions (e.g. central line&#xD;
             insertion/removal) concurrent with the bone marrow procedure&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sara S Zarnegar-Lumley, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Memorial Sloan Kettering Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Memorial Sloan Kettering Cancer Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mskcc.org/</url>
    <description>Memorial Sloan Kettering Cancer Center</description>
  </link>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>October 3, 2016</study_first_submitted>
  <study_first_submitted_qc>October 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 5, 2016</study_first_posted>
  <last_update_submitted>November 6, 2019</last_update_submitted>
  <last_update_submitted_qc>November 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>local Injection</keyword>
  <keyword>pain Medication</keyword>
  <keyword>propofol</keyword>
  <keyword>ropivacaine</keyword>
  <keyword>16-1417</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuroblastoma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>August 19, 2020</submitted>
    <returned>September 4, 2020</returned>
    <submitted>September 8, 2020</submitted>
    <returned>September 28, 2020</returned>
    <submitted>December 16, 2020</submitted>
    <returned>January 11, 2021</returned>
    <submitted>January 27, 2021</submitted>
    <returned>February 15, 2021</returned>
    <submitted>March 25, 2021</submitted>
    <returned>April 19, 2021</returned>
    <submitted>May 12, 2021</submitted>
    <returned>June 7, 2021</returned>
    <submitted>June 7, 2021</submitted>
    <returned>June 28, 2021</returned>
    <submitted>July 22, 2021</submitted>
    <returned>August 16, 2021</returned>
    <submitted>September 15, 2021</submitted>
    <returned>October 11, 2021</returned>
    <submitted>November 12, 2021</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

